Mohammad Nafeli Shahrestani: CXCL10 Associated With Increased Long-Term Risk of Ischemic Stroke
Mohammad Nafeli Shahrestani, Postdoctoral Research Fellow at University of Miami Evelyn F. McKnight Brain Institute, Medical Doctor at Private Practice, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Translational Stroke Research, adding:
“I’m glad to share that our new article has been published in Translational Stroke Research. We performed a large-scale but immune-focused screening of plasma immune markers in the Northern Manhattan Study (NOMAS).
Machine learning-assisted data reduction identified C-X-C motif chemokines as candidate markers of stroke risk. One standard deviation (SD) increase in baseline plasma C-X-C motif chemokine ligand 10 (CXCL10) was associated with a 20% greater risk of all-cause and ischemic stroke over more than a decade of follow-up.
This association was independent of sociodemographic factors, cardiovascular risk factors, comorbidities, MRI-measured white matter disease, and kidney function. The results were internally validated.
CXCL10, a chemokine induced by interferon gamma (IFN-γ), may play a direct role in stroke pathogenesis.
Our findings suggest that CXCL10 is a marker of cerebrovascular disease and may add prognostic value when integrated with clinical, imaging, and laboratory assessments. CXCL10 may also be a target for pharmacological intervention to preserve cerebrovascular health.
I am grateful to all NOMAS participants, my mentors, and my co-authors.”
Title: Chemokine CXCL10 and Incident Stroke Risk in the Northern Manhattan Study
Authors: Mohammad Nafeli Shahrestani, Christian Agudelo, Hannah Gardener, Emir Veledar, Jose A Santiago, Marco R Di Tullio, David Della-Morte, Botagoz Aimagambetova, Jose Gutierrez, Mady Hornig, Mitchell S V Elkind, Hyun Song, Clinton B Wright, Sarah E Tom, Tatjana Rundek

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 4, 2026, 00:23Asim Katbeh: Light Spot on the Spectrum of Ischemic Heart Disease in Women
-
Oct 3, 2026, 17:26Karel Kostev։ When First Anticoagulant Prescriptions Are Not Dispensed
-
Oct 3, 2026, 17:11Nabila Hasan: Thalassemia Awareness And Prevention
-
Oct 3, 2026, 17:03Pasinee Sangsiwarit: Neutrophil Dysfunction In β-Thalassemia
-
Oct 3, 2026, 16:18Mira Kassouf: Reactivating An Embryonic Gene To Treat α-Thalassemia
-
Oct 3, 2026, 15:49Behnood Bikdeli: COATED_AIR Trial Design Published as Enrollment Reaches 3,000 Patients
-
Oct 3, 2026, 15:25Vanrose Panashe Nyamangodo: A Multi-Task Deep Learning Model For Malaria And Anemia
-
Oct 3, 2026, 14:52Benny Sorensen: Glanzmann’s Thrombasthenia Finally Assigned Dedicated ICD-10 Code
-
Oct 3, 2026, 14:52The Real-World Burden Of DVT In Traumatic Fractures – ISTH